Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade C 29.57 2.57% 0.74
CRY closed up 2.57 percent on Friday, September 13, 2019, on 1.57 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CRY trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Crossed Above 200 DMA Bullish 2.57%
Crossed Above 50 DMA Bullish 2.57%

Older signals for CRY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Medicine Laser Surgery Hemodialysis Transplantation Circulatory System End Stage Renal Disease Vascular Surgery Bypass Cardiovascular System Coronary Artery Disease A Solution Treatment Of Coronary Artery Disease
Is CRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.05
52 Week Low 23.99
Average Volume 173,169
200-Day Moving Average 28.8024
50-Day Moving Average 28.1124
20-Day Moving Average 26.8995
10-Day Moving Average 27.304
Average True Range 0.7523
ADX 13.02
+DI 33.5441
-DI 13.1881
Chandelier Exit (Long, 3 ATRs ) 27.4531
Chandelier Exit (Short, 3 ATRs ) 27.7869
Upper Bollinger Band 28.6512
Lower Bollinger Band 25.1478
Percent B (%b) 1.26
BandWidth 13.024034
MACD Line 0.1687
MACD Signal Line -0.2479
MACD Histogram 0.4166
Fundamentals Value
Market Cap 989 Million
Num Shares 33.4 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 89.61
Price-to-Sales 3.65
Price-to-Book 3.05
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.91
Resistance 3 (R3) 30.80 30.26 30.68
Resistance 2 (R2) 30.26 29.92 30.31 30.61
Resistance 1 (R1) 29.91 29.71 30.09 30.02 30.53
Pivot Point 29.37 29.37 29.45 29.42 29.37
Support 1 (S1) 29.02 29.03 29.20 29.13 28.61
Support 2 (S2) 28.48 28.82 28.53 28.53
Support 3 (S3) 28.13 28.48 28.46
Support 4 (S4) 28.24